Leerink Partners Maintains Outperform on Stryker, Lowers Price Target to $407

Benzinga Newsdesk www.benzinga.com Negative 94.2%

Neg 94.2% Neu 0% Pos 0%

Leerink Partners analyst Mike Kratky maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $410 to $407.